Target intelligence / Profile preview

Master Regulatory Gene Network

Molecular classification
Transcription factor, Other
01

Overview

A Master Regulatory Gene Network (MRGN) is a systems biology construct representing a hierarchical collection of genes and their interactions that govern a specific cellular state or developmental pathway (Davidson, 2010). These networks are typically anchored by 'master regulators'—transcription factors that sit at the top of the regulatory hierarchy and control the expression of numerous downstream targets to maintain cell identity (Califano & Alvarez, 2017). In the context of human disease, particularly oncology, MRGNs are often hijacked to maintain a malignant phenotype, where a small set of proteins (the 'bottleneck') integrates signals from various mutations to drive tumor progression (Aibar et al., 2017). While the network itself is a conceptual framework rather than a single druggable molecule, identifying the key nodes within these networks is a major focus of modern drug discovery. Targeting these master regulators offers the potential to reverse entire disease-associated transcriptional programs, though it presents significant challenges regarding specificity and systemic toxicity. Consequently, the term 'Master Regulatory Gene Network' refers to a complex system of multiple targets rather than a single therapeutic entity.

Other names
Gene Regulatory NetworkMaster Regulator NetworkCore Regulatory CircuitTranscriptional Regulatory NetworkMRGN
02

Mechanism of action

Not applicable as a single target; therapeutic strategies typically involve the inhibition or activation of specific protein nodes (e.g., transcription factors) within the network to disrupt the disease-maintaining state.

03

Biological functions

Cell differentiationCell proliferationGene expression regulationSignal transductionCell cycle controlHomeostasis
04

Disease associations

CancerDevelopmental disorderNeurodegenerative diseaseAutoimmune disease
05

Safety considerations

Pleiotropic effects due to broad regulatory influenceSystemic toxicity from disrupting essential homeostatic pathwaysNetwork compensation leading to drug resistanceDifficulty in achieving high specificity for disease-specific network states
06

Biomarkers

Gene expression signaturesTranscriptomic profilesTranscription factor activity scores (e.g., VIPER scores)Chromatin accessibility patterns

Beyond the preview

Go deeper on Master Regulatory Gene Network.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Master Regulatory Gene Network.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call